A Gantt chart is a visual representation of a project schedule, showing the start and finish date of several elements of a ...

The biotechnology company disclosed interim human trial data for its RV-001 optogenetic treatment aiming to restore sight in ...

On a Thursday afternoon, Kevin Acila, 30, sat with her children on a papyrus mat spread across the compound outside her ...

Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced the interim clinical results from its ongoing Phase 1/2 first-in-human trial ...

Last patient visits for both OCS-01 Phase 3 DIAMOND trials (total 800+ patients) are complete, with topline results expected in June 2026A non-invasive ...

Reading stock charts can give you key insights into a company's perceived value. You can learn to recognize signals for when ...

Opus 4.7 utilizes an updated tokenizer that improves text processing efficiency, though it can increase the token count of ...

Annexin Pharmaceuticals AB today announces an update on patient recruitment in the ongoing Phase 2a/Proof of Concept study NEXUS, investigating the drug candidate ANXV in retinal vein occlusion (RVO) ...

In children born very preterm, suboptimal visual acuity (VA) at 5.5 years of age was associated with lower cognitive and motor performance, along with increased behavioural difficulties. Researchers ...

Introduction Children born preterm often have anatomical and functional visual abnormalities, even in the absence of retinopathy of prematurity. This includes suboptimal visual acuity (VA), defined as ...